Home
Sotac Pharmaceuticals Ltd Share Price History
Sotac Pharmaceuticals Ltd
NSE : 19 Feb, 2025
107.52.8 (2.6%)
Prev Close
104.8
Open Price
107.5
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
1200
Today's High / Low
107.5 / 107.5
52 WK High / Low
202.8 / 87.1
Market Price of Sotac Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Sotac Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2020 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 0.38 |
| YoY Gr. | - |
| Net Profit (Cr.) | 0 |
| BVPS | 13.29 |
Key Financial Parameters
| Parameter | 2020 |
|---|---|
| Return on Capital Emp. % | 3.9 |
| Op. Profit Mgn % | 7.15 |
| Net Profit Mgn % | 0.28 |
| Debt to Equity % | 4.39 |
Latest Shareholding
Promoters Holdings Over Time
About Sotac Pharmaceuticals Ltd
- Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of 'M/s Sotac Pharmaceuticals', pursuant to a Deed of Partnership dated October 28, 2015.
- Thereafter 'M/s.
- Sotac Pharmaceuticals' was converted from Partnership Firm to a Private Limited Company in the name of 'Sotac Pharmaceuticals Private Limited' dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat.
- Later on, Company converted into a Public Limited Company and the name of Company was changed to 'Sotac Pharmaceuticals Limited' dated November 22, 2022 issued by Registrar of Companies, Ahmedabad. The Company is a part of SOTAC Group, based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis.
Popular Search
FAQs for Sotac Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Sotac Pharmaceuticals Ltd's share price history?
Key events that impact Sotac Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Sotac Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Sotac Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Sotac Pharmaceuticals Ltd?
Dividends can influence Sotac Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Sotac Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Sotac Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Sotac Pharmaceuticals Ltd’s share price history?
To understand Sotac Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
